Skip to content

Eli Lilly LLY EV / sales

EV / sales at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Pfizer logo
PfizerPFE
3.5×+0.3×
Amgen logo
AmgenAMGN
6.6×+0.1×
Cardinal Health logo
Cardinal HealthCAH
0.2×0.0×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
12.2×+5.7×
Biogen logo
BiogenBIIB
+0.8×

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$979.64B+10.8%
Enterprise value$1.02T+10.6%
P/E38.8×-40.9×
P/S13.6×-4.5×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Calculated from Eli Lilly’s reported figures.

Based on the most recent quarter.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's EV / sales?
Eli Lilly (LLY) reported EV / sales of 11.9× in Q1 2026.
How has Eli Lilly's EV / sales changed year-over-year?
Eli Lilly's EV / sales decreased by 25.0% year-over-year, from 15.9× to 11.9×.
What is the long-term trend for Eli Lilly's EV / sales?
Over 5 years (2020 to 2025), Eli Lilly's EV / sales has grown at a 16.5% compound annual growth rate (CAGR), from 7.1× to 15.3×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.